| Whole-Exome sequencing identifies GYS2 biallelic variants in individuals with suspected epilepsy. | Whole-Exome sequencing identifies GYS2 biallelic variants in individuals with suspected epilepsy.
Ilyas M, Holzwarth D, Ishaq R, Ali Y, Habiba U, Raja AM, Saeed S, Abdullah U, Khan SN, Ullah A, Raja GK, Baig SM, Fazeli W, Kunz WS, Shaiq PA. | 04/15/2024 |
| Value of glycogen synthase 2 in intrahepatic cholangiocarcinoma prognosis assessment and its influence on the activity of cancer cells. | Value of glycogen synthase 2 in intrahepatic cholangiocarcinoma prognosis assessment and its influence on the activity of cancer cells.
A S, Wu H, Wang X, Wang X, Yang J, Xia L, Xia Y., Free PMC Article | 02/19/2022 |
| A patient with glycogen storage disease type 0 and a novel sequence variant in GYS2: a case report and literature review. | A patient with glycogen storage disease type 0 and a novel sequence variant in GYS2: a case report and literature review.
Arko JJ, Debeljak M, Tansek MZ, Battelino T, Groselj U., Free PMC Article | 07/10/2021 |
| Findings suggest that GYS2 serves as a prognostic factor and functions as a tumor suppressor in HCC. The newly identified HBx/GYS2/p53 axis is responsible for the deregulation of glycogen metabolism. | A GYS2/p53 Negative Feedback Loop Restricts Tumor Growth in HBV-Related Hepatocellular Carcinoma.
Chen SL, Zhang CZ, Liu LL, Lu SX, Pan YH, Wang CH, He YF, Lin CS, Yang X, Xie D, Yun JP. | 11/23/2019 |
| Mutation in GYS2 gene is associated with hepatic glycogen synthase deficiency. | The variable clinical phenotype of three patients with hepatic glycogen synthase deficiency.
Kasapkara ÇS, Aycan Z, Açoğlu E, Senel S, Oguz MM, Ceylaner S. | 09/16/2017 |
| Sequencing of the GYS2 gene is more likely to be positive in patients with fasting ketotic hypoglycaemia and concomitant postprandial hyperglycaemia with hyperlactataemia. | Mutational analysis of the GYS2 gene in patients diagnosed with ketotic hypoglycaemia.
Nessa A, Kumaran A, Kirk R, Dalton A, Ismail D, Hussain K. | 04/27/2013 |
| The GYS2 gene is a new susceptibility gene that significantly affects the risk for ovary syndrome through obesity-related conditions. | Genome-wide association study identifies GYS2 as a novel genetic factor for polycystic ovary syndrome through obesity-related condition.
Hwang JY, Lee EJ, Jin Go M, Sung YA, Lee HJ, Heon Kwak S, Jang HC, Soo Park K, Lee HJ, Byul Jang H, Song J, Park KH, Kim HL, Cho MC, Lee JY. | 04/6/2013 |
| Observational study of gene-disease association. (HuGE Navigator) | See all PubMed (3) articlesInvestigation of genetic susceptibility factors for human longevity - a targeted nonsynonymous SNP study.
Flachsbart F, Franke A, Kleindorp R, Caliebe A, Blanché H, Schreiber S, Nebel A. Genetic associations of brain structural networks in schizophrenia: a preliminary study.
Jagannathan K, Calhoun VD, Gelernter J, Stevens MC, Liu J, Bolognani F, Windemuth A, Ruaño G, Assaf M, Pearlson GD. Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?
Ruaño G, Thompson PD, Kane JP, Pullinger CR, Windemuth A, Seip RL, Kocherla M, Holford TR, Wu AH. | 09/15/2010 |
| Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator) | Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.
Rose JE, Behm FM, Drgon T, Johnson C, Uhl GR., Free PMC Article | 06/30/2010 |
| Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator) | Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazone.
Ruaño G, Bernene J, Windemuth A, Bower B, Wencker D, Seip RL, Kocherla M, Holford TR, Petit WA, Hanks S. | 12/23/2009 |
| Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator) | A study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus.
Watanabe I, Tomita A, Shimizu M, Sugawara M, Yasumo H, Koishi R, Takahashi T, Miyoshi K, Nakamura K, Izumi T, Matsushita Y, Furukawa H, Haruyama H, Koga T. | 03/13/2008 |